REBIOTIX
Rebiotix is a development-stage biotechnology company revolutionizing the treatment of challenging GI diseases by harnessing the power of the human microbiome.
REBIOTIX
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2011-01-01
Address:
Rockville, Minnesota, United States
Country:
United States
Website Url:
http://www.rebiotix.com
Total Employee:
11+
Status:
Active
Contact:
+1 651 705 8770
Total Funding:
36.32 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
BioFluidica
BioFluidica is a biotechnology company that has developed a diagnostic platform.
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Current Employees Featured
Erwin Kelen Founder @ Rebiotix
Founder
Lee Jones Founder,President & CEO @ Rebiotix
Founder,President & CEO
2011-11-01
Founder
Investors List
Sofia Fund
Sofia Fund investment in Convertible Note - Rebiotix
Sofia Fund
Sofia Fund investment in Series A - Rebiotix
Official Site Inspections
http://www.rebiotix.com Semrush global rank: 453.71 K Semrush visits lastest month: 115.09 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Rebiotix"
Rebiotix
Rebiotix Inc. has been integrated into Ferring Pharmaceuticals. If you would like to continue to the Ferring U.S. website click on FerringUSA.com below. FerringUSA.com. If you are interested in …See details»
Rebiotix Inc (a Ferring Company) - LinkedIn
Rebiotix Inc, part of the Ferring Pharmaceuticals Group, is a clinical-stage biotechnology company revolutionizing the treatment of challenging gastrointestinal diseases by harnessing the...See details»
Rebiotix - Crunchbase Company Profile & Funding
Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome. View contacts for Rebiotix to access new leads and connect with decision-makers.See details»
Rebiotix, Inc. - BioCT
Rebiotix Inc., a subsidiary of the Ferring Pharmaceuticals Group, is a clinical stage biotechnology company founded to revolutionize the treatment of debilitating diseases by harnessing the …See details»
Ferring acquires innovative biotechnology company and …
Rebiotix Company Profile 2024: Valuation, Investors, …
Developer of human microbe drugs designed for the treatment of gastrointestinal diseases. The company's drug represents a new approach to the treatment of diseases by delivering live, human-derived microbes into a sick patient's …See details»
Rebiotix Company Profile - Office Locations, Competitors, Revenue ...
Rebiotix Inc is a clinical stage biotechnology company founded to revolutionize the treatment of debilitating gastrointestinal (GI) diseases by harnessing the power of the human microbiome. …See details»
Lee Jones - Founder, President & CEO at Rebiotix | The Org
Lee Jones is the founder, president, and chief executive officer of Rebiotix, a results-oriented biotechnology company revolutionizing the treatment of challenging gastrointestinal diseases …See details»
Ferring acquires innovative biotechnology company and …
This acquisition brings together two innovative healthcare companies that share a common commitment to exploring and understanding the human microbiome to develop new solutions …See details»
FDA advisers back microbiota-based treatment for gut infection
Sep 22, 2022 · Rebiotix is one of several companies pursuing microbiota-based medicines to treat C. diff, a drug-resistant bacteria responsible for half a million infections annually. It can cause …See details»
Rebiotix - Funding, Financials, Valuation & Investors - Crunchbase
Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome.See details»
Rebiotix - Overview, News & Similar companies | ZoomInfo.com
Oct 25, 2021 · View Rebiotix (www.rebiotix.com) location in Minnesota, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Rebiotix Treats First Patient in Phase 1 Study of RBX7455, an Orally ...
ROSEVILLE, Minn., Jan. 4, 2017 /PRNewswire/ -- Rebiotix Inc., a clinical-stage biotechnology company focused on harnessing the power of the human microbiome to treat challenging …See details»
Ferring, Rebiotix and MyBiotics Collaborate to Develop Live …
Feb 17, 2021 · Rebiotix Inc, a Ferring Company, is a late-stage clinical microbiome company focused on harnessing the power of the human microbiome to revolutionise the treatment of …See details»
Rebiotix - Quality Assurance and Control - The Org
The Quality Assurance and Control team at Rebiotix ensures that all processes, products, and systems meet stringent regulatory standards and quality benchmarks.See details»
How Rebiotix Avoids The Typical Biopharma Startup Missteps
Sep 1, 2016 · Lee Jones, the CEO and cofounder of Rebiotix, describes building the company in an “of course, this is how you do it” manner. The larger issue — whether the company’s …See details»
Rebiotix, a Ferring Company, Completes Enrollment for First-Ever ...
Feb 4, 2020 · Rebiotix Inc., part of the Ferring Pharmaceuticals Group, is a late-stage clinical microbiome company focused on harnessing the power of the human microbiome to …See details»
FDA advisory committee votes for approval of first microbiome …
Oct 10, 2022 · Rebiotix’s microbiota-based RBX2660 could secure FDA approval to reduce C. difficile infection recurrence, following a positive vote from the agency’s advisory committee.See details»
Rebiotix Receives Breakthrough Therapy Designation for RBX2660
Oct 12, 2015 · MRT is the Rebiotix drug platform for delivering healthy, live, human-derived microbes into a sick patient's intestinal tract to treat disease. Studies have shown that most …See details»
RBX-8225 - Drug Targets, Indications, Patents - Synapse - Patsnap
Now, its global highest R&D status is Clinical, Mechanism: Bacteria replacements,Gastrointestinal microbiome modulators, Therapeutic Areas: Digestive System Disorders, Active Indication: …See details»